Pharmacogenomics and Precision Medicine an Evolving Analytical Clinical Tools for Future Medicine – A Narrative Review

Year : 2024 | Volume : | : | Page : –
By

Mekkanti Manasa Rekha,

Soumitra Das,

  1. Associate Professor, Department of Pharmacy Practice, Aditya Bangalore Institute of Pharmacy Education and Research, Bangalore,, Karnataka, India
  2. Student, Department of Pharmacy Practice, Aditya Bangalore Institute of Pharmacy Education and Research, Bangalore, Karnataka, India

Abstract

The term Pharmacogenomics is coined as an emerging field that exactly examines how the genetic variations influence the individual responses towards medications. This discipline in turn integrates the pharmacology as well as genomics to facilitate the personalized medicine, encouraging the healthcare providers to tailor their drug therapies based on individual patient’s genetic profile. Key applications include optimizing drug efficacy, minimizing adverse effects, and enhancing treatment outcomes across various medical fields such as oncology, cardiology, and psychiatry. As genetic testing becomes more accessible, pharmacogenomics is poised to revolutionize healthcare by promoting precision medicine, improving patient care, and reducing healthcare costs. However, the other challenges such as cost, accessibility, as well as ethical considerations must be addressed to fully realize its potential.

Keywords: Pharmacogenomics, personalized medicine, genetic variations, drug response, precision medicine, drug metabolism, adverse effects, clinical applications, healthcare costs, ethical considerations.

How to cite this article: Mekkanti Manasa Rekha, Soumitra Das. Pharmacogenomics and Precision Medicine an Evolving Analytical Clinical Tools for Future Medicine – A Narrative Review. Research & Reviews: A Journal of Pharmaceutical Science. 2024; ():-.
How to cite this URL: Mekkanti Manasa Rekha, Soumitra Das. Pharmacogenomics and Precision Medicine an Evolving Analytical Clinical Tools for Future Medicine – A Narrative Review. Research & Reviews: A Journal of Pharmaceutical Science. 2024; ():-. Available from: https://journals.stmjournals.com/rrjops/article=2024/view=172100

References

  1. Polasek TM, Shakib S, Rostami-Hodjegan A. Precision dosing in clinical medicine: present and future. Expert review of clinical pharmacology. 2018 Aug 3;11(8):743-6.
  2. Crews KR, Hicks JK, Pui CH, Relling MV, Evans WE. Pharmacogenomics and individualized medicine: translating science into practice. Clinical Pharmacology & Therapeutics. 2012 Oct;92(4):467-75.
  3. Gurwitz D, Weizman A, Rehavi M. Education: teaching pharmacogenomics to prepare future physicians and researchers for personalized medicine. Trends in pharmacological sciences. 2003 Mar 1;24(3):122-5.
  4. Lee SJ. Clinical application of CYP2C19 pharmacogenetics toward more personalized medicine. Frontiers in genetics. 2013 Feb 1;3:318. https://doi.org/10.3389/fgene.2012.00318
  5. Koning PD, Keirns J. Clinical pharmacology, biomarkers and personalized medicine: education please. Biomarkers in Medicine. 2009 Dec 1;3(6):685-700.
  6. Carr DF, Alfirevic A, Pirmohamed M. Pharmacogenomics: current state-of-the-art. Genes. 2014 May 26;5(2):430-43.
  7. Everett JR. Pharmacometabonomics in humans: a new tool for personalized medicine. Pharmacogenomics. 2015 May 1;16(7):737-54.
  8. Everett JR. From metabonomics to pharmacometabonomics: the role of metabolic profiling in personalized medicine. Frontiers in pharmacology. 2016 Sep 8;7:297.
  9. Ziegelstein RC. Personomics: The missing link in the evolution from precision medicine to personalized medicine. Journal of Personalized Medicine. 2017 Oct 16;7(4):11.
  10. De Leon J. Pharmacogenomics: the promise of personalized medicine for CNS disorders. Neuropsychopharmacology. 2009 Jan;34(1):159-72. https://doi.org/10.1038/npp.2008.147
  11. Drăgoi CM, Nicolae AC, Dumitrescu IB. Emerging Strategies in Drug Development and Clinical Care in the Era of Personalized and Precision Medicine. Pharmaceutics. 2024 Aug 22;16(8):1107.
  12. Farmaki A, Manolopoulos E, Natsiavas P. Will Precision Medicine Meet Digital Health? A Systematic Review of Pharmacogenomics Clinical Decision Support Systems Used in Clinical Practice. OMICS: A Journal of Integrative Biology. 2024 Vol 28, No.9 https://doi.org/10.1089/omi.2024.0131.
  13. Manchia, M., Pisanu, C., Squassina, A., & Carpiniello, B. (2020). Challenges and Future Prospects of Precision Medicine in Psychiatry. Pharmacogenomics and Personalized Medicine, 13, 127–140. https://doi.org/10.2147/PGPM.S198225.
  14. Scheen AJ. Precision medicine: the future in diabetes care?. Diabetes Research and Clinical Practice. 2016 Jul 1;Vol:117:PP12-21. https://doi.org/10.1016/j.diabres.2016.04.033
  15. Sim SC, Ingelman-Sundberg M. Pharmacogenomic biomarkers: new tools in current and future drug therapy. Trends in pharmacological sciences. 2011 Feb 1;Vol;32(2):72-81.
  16. Lindpaintner, K. Pharmacogenetics and the future of medical practice. J Mol Med 81, 141–153 (2003). https://doi.org/10.1007/s00109-002-0416-5
  17. Agyeman AA, Ofori-Asenso R. Perspective: Does personalized medicine hold the future for medicine? Journal of Pharmacy and Bioallied Sciences. 2015 Jul 1;7(3):239-44.
  18. Wei CY, Michael Lee MT, Chen YT. Pharmacogenomics of adverse drug reactions: implementing personalized medicine. Human molecular genetics. 2012 Oct 15;21(R1):R58-65.
  19. Ritchie MD. The success of pharmacogenomics in moving genetic association studies from bench to bedside: study design and implementation of precision medicine in the post-GWAS era. Human genetics. 2012 Oct;131:1615-26.
  20. Sadee W, Dai Z. Pharmacogenetics/genomics and personalized medicine. Human molecular genetics. 2005 Oct 15;14(suppl_2): R207-14. https://doi.org/10.1093/hmg/ddi261
  21. Iriart JA. Precision medicine/personalized medicine: a critical analysis of movements in the transformation of biomedicine in the early 21st century. Public Health Journal 2019 Mar 25;35: (3) https://doi.org/10.1590/0102-311X00153118
  22. Mishra PJ, Bertino JR. MicroRNA polymorphisms: the future of pharmacogenomics, molecular epidemiology and individualized medicine. Pharmacogenomics. 2009 Mar 1;10(3):399-416.
  23. Duffy DJ. Problems, challenges and promises perspectives on precision medicine. Briefings in bioinformatics. 2016 May 1;17(3):494-504. https://doi.org/10.1093/bib/bbv060
  24. Seyhan AA, Carini C. Are innovation and new technologies in precision medicine paving a new era in patients centric care? Journal of translational medicine. 2019 Apr 5;17(1):114.
  25. Giri J, Moyer AM, Bielinski SJ, Caraballo PJ. Concepts driving pharmacogenomics implementation into everyday healthcare. Pharmacogenomics and Personalized Medicine. 2019 Oct 30:305-18.
  26. Love-Koh J, Peel A, Rejon-Parrilla JC, Ennis K, Lovett R, Manca A, Chalkidou A, Wood H, Taylor M. The future of precision medicine: potential impacts for health technology assessment. Pharmacoeconomics. 2018 Dec; 36:1439-51.
  27. Xie HG, Frueh FW. Pharmacogenomics steps toward personalized medicine. Personalized medicine. 2005 Nov 1;2(4):325-37.
  28. De Maria Marchiano R, Di Sante G, Piro G, Carbone C, Tortora G, Boldrini L, Pietragalla A, Daniele G, Tredicine M, Cesario A, Valentini V. Translational research in the era of precision medicine: where we are and where we will go. Journal of Personalized Medicine. 2021 Mar 18;11(3):216.
  29. Oates JT, Lopez D. Pharmacogenetics: an important part of drug development with a focus on its application. International journal of biomedical investigation. 2018;1(2): doi: 10.31531/2581-4745.1000111.
  30. Fountzilas E, Tsimberidou AM, Vo HH, Kurzrock R. Clinical trial design in the era of precision medicine. Genome medicine. 2022 Aug 31;14(1):101.

 

 

Ahead of Print Subscription Review Article
Volume
Received August 16, 2024
Accepted September 4, 2024
Published September 14, 2024
Views: 37

Check Our other Platform for Workshops in the field of AI, Biotechnology & Nanotechnology.
Learn more
Check Out Platform for Webinars in the field of AI, Biotech. & Nanotech.
Learn more